Multicenter CATCOVID trial for treating severe COVID-19 progression enrolls first patient
The clinical phase II trial CATCOVID initiated by the Berlin Institute of Health at Charité (BIH) has cleared the final regulatory hurdles with the receipt of a positive ethics committee vote and w…
